{{Rsnum
|rsid=12415607
|Gene=CASP7
|Chromosome=10
|position=115438204
|Orientation=plus
|GMAF=0.2635
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 5.3 | 37.2 | 57.5
| HCB | 15.3 | 51.8 | 32.8
| JPT | 23.0 | 51.3 | 25.7
| YRI | 1.4 | 19.7 | 78.9
| ASW | 5.3 | 22.8 | 71.9
| CHB | 15.3 | 51.8 | 32.8
| CHD | 16.5 | 54.1 | 29.4
| GIH | 7.9 | 38.6 | 53.5
| LWK | 0.9 | 34.5 | 64.5
| MEX | 13.8 | 37.9 | 48.3
| MKK | 9.0 | 37.8 | 53.2
| TSI | 6.9 | 34.3 | 58.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19058873
|Title=Polymorphisms in the Caspase7 gene and the risk of lung cancer
}}

{{PMID Auto
|PMID=22441531
|Title=Association of CASP7 Polymorphisms and Survival of Non-Small-Cell Lung Cancer Patients with Platinum-Based Chemotherapy Treatment
}}

{{PMID Auto
|PMID=19531679
|Title=Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.
|OA=1
}}

{{PMID Auto
|PMID=19604093
|Title=Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.
|OA=1
}}

{{PMID Auto
|PMID=23765963
|Title=HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}